IR Biosciences Holdings, Inc. (IRBS)

Other OTC - Other OTC Delayed Price. Currency in USD

0.0000

(0.00%)

At close: 08:30AM EST

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.0000
Open	0.0000
Bid	0.0000 x 0
Ask	0.0000 x 0
Day's Range	0.0000 - 0.0000
52 Week Range	0.0000 - 0.0000
Volume	144
Avg. Volume	2,572

Market Cap	17
Beta (5Y Monthly)	400.11
PE Ratio (TTM)	N/A
EPS (TTM)	-0.3420
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	2.00

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for IRBS

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

IR BIOSCIENCES HOLDINGS INC
ANIP: What does Argus have to say about ANIP?ANI PHARMACEUTICALS INC has an Investment Rating of BUY; a target price of $55.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of High.
Rating
Fair Value
Economic Moat
3 days agoArgus Research